Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06281249 · ClinicalTrials.gov registry record · NA
Neuraxial Ultrasound Device Study
A NA study, sponsored by Stanford University.
- Not yet
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT06281249: Clinical Trial NA study, sponsored by Stanford University.
NCT06281249 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06281249, a NA study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The aim of the study is to develop a device that can eliminate failed neuraxial placements in challenging patients.The study will attempt to improve safety and efficacy of neuraxial anesthesia with high precision real-time needle visualization through automated real-time needle guidance at the bedside with an experimental device (Accuro 3S). Investigators will verify the clinical workflow for utilizing the Accuro 3S during epidural and spinal procedures and validation of needle visualization while using the device as well as anatomical guidance provided by the device during spinal imaging.The underlying bone imaging enhancement algorithms were introduced in the commercially available FDA approved Accuro. The Accuro 3S will be used to establish needle insertion point and trajectory, after which the clinician will use standard of care methods to advance the needle such as the loss of resistance method.
Interventions
- DEVICE Ultrasound placement device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-12-15 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06281249
The ClinicalTrials.gov registry entry for NCT06281249 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ultrasound placement device is the first listed.
NCT06281249 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06281249 about?
NCT06281249 is a clinical study titled "Neuraxial Ultrasound Device Study". The aim of the study is to develop a device that can eliminate failed neuraxial placements in challenging patients.The study will attempt to improve safety and efficacy of neuraxial anesthesia with high precision real-time needle visualization through automated real-time needle guidance at the bedsi...
What is the current status of trial NCT06281249?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-12-15. Estimated completion is 2027-12.
What interventions are being tested in trial NCT06281249?
The interventions under investigation include: Ultrasound placement device (DEVICE).
Who is sponsoring clinical trial NCT06281249?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.